Abstracts tagged "Arthritis and pain"

Abstract Number: 1430 • 2015 ACR/ARHP Annual Meeting
Peripheral HMGB1 Regulates Arthrtis-Associated Pain-like Behaviour
Nilesh Agalave¹, Teresa Fernandez Zafra², Peter Lundback³, Ulf Andersson⁴, Helena E. Harris³ and Camilla Svensson⁵, ¹Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden, ²Physiology and pharmacology, Karolinska Institutet, Stockholm, Sweden, ³Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden, ⁴Center for Molecular medicine, Karolinska Institutet, Stockholm, Sweden, ⁵Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: HMGB1 has received attention for its emerging roles in the extracellular environment acting as damage associated molecular pattern molecule. The redox state of HMGB1…
Abstract Number: 352 • 2014 ACR/ARHP Annual Meeting
Remaining Pain in Spite of Suppressed Inflammation in Early Rheumatoid Arthritis – Long-Term Strongly Increased Risk for Widespread Pain and Fatigue
Maria E.C. Sandberg¹, Saedis Saevarsdottir², Reem Altawil³, Lars Klareskog⁴, Lars Alfredsson¹ and Jon Lampa³, ¹The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ²Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, ³Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, ⁴Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden
Background/Purpose: Pain is common in rheumatoid arthritis (RA), even after adequate inflammatory disease control. Important long-term health effects of RA are fatigue, sleeping disturbances and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].